Atypical teratoid/rhabdoid tumor

Changed by Amir Rezaee, 11 Apr 2015

Updates to Article Attributes

Body was changed:

Atypical teratoid/rhabdoid tumours (AT/RTs) are an uncommon WHO Grade IV tumour, which in the vast majority of cases occurs in young children less than two years of age. It most frequently presents as a posterior fossa mass

AT/RTs were until relatively recently classed as medulloblastomas, although both clinically and histologically they are different entities.

Epidemiology

They present in young children (median age is less than 2-3 years 2), whereas medulloblastomas typically occur in mid childhood (median age 6 years).

Pathology

Rhabdoid cells are the hallmark of AT/RT which however make up only a tiny fraction of the tumour, which is otherwise indistinguishable on imaging and histology from a medulloblastoma or sPNET. However, almost all AT/RTs show loss of INI1 tumour suppressor gene on chromosome 22 which distinguishes them from other entities 8.

Markers

Relatively specific markers include:

  • epithelial membrane antigen
  • vimentin
  • smooth muscle actin
Location

Radiographic features

CT brain
  • often isodense to gray matter
  • may demonstrate heterogeneous enhancement
  • calcification is common
  • may show associated obstructive hydrocephalus
MRI brain

Can show necrosis, multiple foci of cyst formation and sometimes haemorrhage:

  • T1: iso- to slightly hyperintense to grey matter (haemorrhagic areas can be more hyperintense)
  • T2: generally hyperintense (haemorrhagic areas can be hypointense)
  • T1 C+ (Gd): heterogeneous enhancement
  • MR spectroscopy: 
    • Cho: elevated
    • NAA: decreased

Treatment and prognosis

Surgery with debulking can be offered in some cases. Tumours can demonstrate leptomeningeal dissemination. Clinically AT/RTs have much poorer prognosis than medulloblastomas, with little if any response to chemotherapy, and death usually occuring within a year of diagnosis. 

Differential diagnosis

Imaging differenial considerations include:

  • -<p>A<strong>typical teratoid/rhabdoid tumours</strong> <strong>(AT/RTs)</strong> are an uncommon <a href="/articles/cns-tumours-classification-who">WHO Grade IV</a> tumour, which in the vast majority of cases occurs in young children less than two years of age. It most frequently presents as a <a href="/articles/posterior-fossa-tumours">posterior fossa mass</a>. </p><p>AT/RTs were until relatively recently classed as <a href="/articles/medulloblastoma">medulloblastomas</a>, although both clinically and histologically they are different entities.</p><h4>Epidemiology</h4><p>They present in young children (median age is less than 2-3 years <sup>2</sup>), whereas medulloblastomas typically occur in mid childhood (median age 6 years).</p><h4>Pathology</h4><p>Rhabdoid cells are the hallmark of AT/RT which however make up only a tiny fraction of the tumour, which is otherwise indistinguishable from a medulloblastoma or <a href="/articles/primitive-neuroectodermal-tumour-of-the-cns">sPNET</a>.</p><h5>Markers</h5><p>Relatively specific markers include:</p><ul>
  • +<p>A<strong>typical teratoid/rhabdoid tumours</strong> <strong>(AT/RTs)</strong> are an uncommon <a href="/articles/cns-tumours-classification-and-grading-who">WHO Grade IV</a> tumour, which in the vast majority of cases occurs in young children less than two years of age. It most frequently presents as a <a href="/articles/posterior-fossa-tumours">posterior fossa mass</a>. </p><p>AT/RTs were until relatively recently classed as <a href="/articles/medulloblastoma">medulloblastomas</a>, although both clinically and histologically they are different entities.</p><h4>Epidemiology</h4><p>They present in young children (median age is less than 2-3 years <sup>2</sup>), whereas medulloblastomas typically occur in mid childhood (median age 6 years).</p><h4>Pathology</h4><p>Rhabdoid cells are the hallmark of AT/RT which however make up only a tiny fraction of the tumour, which is otherwise indistinguishable on imaging and histology from a medulloblastoma or <a href="/articles/primitive-neuroectodermal-tumour-of-the-cns">sPNET</a>. However, almost all AT/RTs show loss of INI1 tumour suppressor gene on chromosome 22 which distinguishes them from other entities <sup>8</sup>.</p><h5>Markers</h5><p>Relatively specific markers include:</p><ul>

References changed:

  • 8. Judkins AR, Burger PC, Hamilton RL et-al. INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma. J. Neuropathol. Exp. Neurol. 2005;64 (5): 391-7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15892296">Pubmed citation</a><span class="auto"></span>
Images Changes:

Image ( destroy )

Image ( destroy )

Image 1 CT (non-contrast) ( update )

Caption was changed:
Case 1: ATRT NCCT

Image 4 MRI (T2) ( update )

Caption was changed:
Case 2: T2

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.